%0 Journal Article
%T Cardiovascular Disease Risk of Hashimoto Thyroiditis Patients According to the TEKHARF Points System
%A Muammer Bilici
%J -
%D 2019
%X Aim: In this study, we aimed to assess the association between thyroid functions and cardiovascular disease (CVD) risk in patients with Hashimoto thyroiditis over TEKHARF points system. Material and Methods: From August to October 2018, 69 patients attending B¨¹lent Ecevit University Faculty of Medicine Hospital Internal diseases clinic with Hashimoto thyroiditis diagnosis receiving levothyroxine treatment were retrospectively investigated in terms of cardiovascular disease etiologic risk factors and thyroid function values. Those with thyroid surgery and malignancy history were not included in the study. CVD risk status was determined as low, moderate and high according to the TEKHARF points system. According to serum thyroid gland stimulating hormone (TSH) levels, two groups were defined as those <2.5 mIU/L TSH and those above. The correlation between TSH levels and CVD risk status was analyzed. Results: Of those participating in the study 87% were female and the mean age of patients was 42.71¡À14.15 years. According to the TEKHARF points scale, 65.2% of participants were in the low risk group, 21.7% were in the moderate risk group and 13% were in the high risk group. There was no correlation identified between serum TSH levels and CVD risk points (p=0.420; r=0.099). The serum triglyceride levels of those with TSH <2.5 mIU/L were found to be significantly low. Additionally, there was no significant correlation between serum LDL and HDL cholesterol levels (p=0.685 and p=0.247, respectively). Conclusion: Achieving target TSH levels in Hashimoto thyroiditis patients may contribute to reducing the CVD risk
%K Kardiovask¨¹ler hastal£¿k riski
%K TEKHARF
%K Hashimoto tiroidi
%U http://dergipark.org.tr/tudod/issue/44870/552343